在社区居住的老年人认知衰退的可修改风险因素因性别和APOE4不同而有所不同
Emilie T Reas1, Humberto Parada2,3, Jaclyn Bergstrom4
1Department of Neurosciences, University of California San Diego, La Jolla, California, USA.
概括
生活方式因素显著影响认知衰老. 管理心脏代谢健康,并从事身体,认知和社会活动,可以保持多达十年的认知健康.
科学领域:
- 老年学和认知神经科学
- 公共卫生和流行病学
背景情况:
- 生活方式对认知衰老轨迹的影响尚未完全理解.
- 确定缓解与年龄相关的认知衰退的关键因素至关重要.
研究的目的:
- 研究生活方式如何影响认知衰老.
- 确定最能预测和潜在地减轻认知衰退的因素.
主要方法:
- 在27年的时间里,对1489名参与者的纵向分析 (兰乔·伯纳多研究).
- 对24个基线风险变量进行了因子分析,将其分为9个复合因素.
- 混合效应模型通过基线因素评估认知变化预测,按性别和APOE4状态分层.
主要成果:
- 超脂血症,肥胖,抑郁症和低体力活动与更快的认知衰退有关.
- 对于男性与女性以及APOE4携带者与非携带者而言,出现了不同的风险概况.
- 与高风险个人资料相比,低风险个人资料可以保持7至9.5年的认知健康寿命.
结论:
- 专注于心脏代谢健康和参与的多因素,终身策略对于减轻认知衰退至关重要.
- 个性化,多领域的方法是必不可少的,考虑到性别和APOE4相关的风险差异和潜在的干预措施.
相关概念视频
Alzheimer's Disease: Overview
439
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439
Cognitive Development During Adulthood
49
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
49
Aging
36
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
36
Dementia
93
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
93
Human Genetics
529
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
529
Alzheimer's Disease: Treatment
160
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
160


